secwatch.observer — SEC 8-K summary
======================================

Issuer:     HAEMONETICS CORP (HAE)
CIK:        0000313143
Form:       8-K
Filed at:   2022-08-08T23:59:59+00:00
Accession:  0000313143-22-000045
Event type: leadership
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Haemonetics names CFO James D'Arecca as principal accounting officer following controller's departure
--------------------------------------------------------------------------------

- James C. D'Arecca, EVP/CFO, assumes principal accounting officer role effective Aug 5, 2022, replacing departing controller Dan Goldstein.
- 2022 annual meeting held Aug 5 with 94.1% quorum; all nine director nominees elected with majority support.
- Shareholders approved say-on-pay (43.98M for, 2.71M against) and ratified Ernst & Young as auditor (47.09M for, 1.16M against).
- Vote totals show high approval for most directors; Charles Dockendorff and Ellen Zane received the most withhold votes at 5.96M and 3.27M, respectively.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000045/0000313143-22-000045-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/313143/000031314322000045/hae-20220805.htm
  HTML page:      https://secwatch.observer/filing/0000313143-22-000045

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer